Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment
Phase of Trial: Phase IV
Latest Information Update: 19 May 2015
At a glance
- Drugs Adalimumab (Primary)
- Indications Psoriasis; Psoriatic arthritis
- Focus Therapeutic Use
- Acronyms TOGETHER
- Sponsors Abbott Laboratories; AbbVie
- 10 Jun 2017 Biomarkers information updated
- 14 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.